Statement re Purchase of Own Shares

Bioquell PLC

("Bioquell", or "the Company")

Purchase of own shares

Further to the Company's announcement on 13 March 2017 stating its intention to reduce its capital by means of purchasing its shares from time to time using existing cash resources, the Company announces that on 13 March 2017 it purchased 25,000 of its ordinary shares on the London Stock Exchange at a price of 135 pence per share. The purchased shares will all be held as treasury shares.

Total Number of Voting Rights

The issued share capital of the Company is comprised of 22,944,780 ordinary shares of 10p each. As 632,000 of these ordinary shares are held as treasury shares, the total number of voting rights in the Company is 22,312,780. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries:

Mark Taylor